Home / Inspections / 1071273

FDA Inspection 1071273 — Everest Life Sciences LLC

Everest Life Sciences LLC — FEI 2243092

The FDA completed an inspection of Everest Life Sciences LLC on October 23, 2018 in Plainsboro, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 23, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plainsboro, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1267697 (VAI Wed Apr 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1063269 (NAI Fri Jul 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 964002 (NAI Wed Mar 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 778012 (VAI Mon Apr 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 710185 (VAI Fri Feb 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources